CYTOKINETICS: PLANS TO SUBMIT SUPPLEMENTAL NDA TO U.S. FDA FOR AFICAMTEN FOR TREATMENT OF ADULT PATIENTS WITH SYMPTOMATIC NHCM IN Q4

Reuters · 2d ago

Please log in to view news